Xi Chen Lin
Director Técnico/Científico/I+D en STRUCTURE THERAPEUTICS INC. .
Fortuna: 976 962 $ al 31/05/2024
Perfil
Xi Chen Lin is currently the Chief Scientific Officer at Structure Therapeutics, Inc. and also holds a position as General Manager at Shanghai ShouTi Biotechnology Co. Ltd.
Prior to these roles, Dr. Lin worked as the Head-Asia Pacific External Innovation at Novo Nordisk A from 2016 to 2019.
Dr. Lin received an undergraduate degree from Peking University and a doctorate degree from The Pennsylvania State University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 03/06/2024 | 85 707 ( 0.06% ) | 976 962 $ | 31/05/2024 |
Cargos activos de Xi Chen Lin
| Empresas | Cargo | Inicio |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Director Técnico/Científico/I+D | 01/07/2019 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Director Ejecutivo | - |
Antiguos cargos conocidos de Xi Chen Lin.
| Empresas | Cargo | Fin |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/07/2019 |
Formación de Xi Chen Lin.
| Peking University | Undergraduate Degree |
| The Pennsylvania State University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| NOVO NORDISK A/S | Health Technology |
| Empresas privadas | 1 |
|---|---|
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Health Technology |
- Bolsa de valores
- Insiders
- Xi Chen Lin
